European Healthcare Acquisition & Growth Company B.V.
European Healthcare Acquisition & Growth Company B.V. reconvenes its annual general meeting of shareholders subject to extension of temporary Dutch COVID-19 Act (Tijdelijke wet Justitie en Veiligheid) (news with additional features)

European Healthcare Acquisition & Growth Company B.V. reconvenes its annual general meeting of shareholders subject to extension of temporary Dutch COVID-19 Act (Tijdelijke wet Justitie en Veiligheid)

Munich, 19 May 2022

Today, European Healthcare Acquisition & Growth Company B.V. (“EHC“), a Dutch operators-led special purpose acquisition company listed on Euronext Amsterdam aiming to acquire one or more companies in the European healthcare sector, reconvenes its annual general meeting of shareholders to be held on 30 June 2022 at 10:00 CEST at Gustav Mahlerplein 50, 1082 MA Amsterdam, the Netherlands (“AGM“) due to the possibility that the temporary Dutch COVID-19 Act (Tijdelijke wet COVID-19 Justitie en Veiligheid) (“COVID-19 Act“) will not be extended. Shareholders will have the opportunity to attend the AGM virtually and in person. The Company urges the shareholders to cast their votes online or by proxy. Shareholders have the option to vote without attending the AGM.

In the event that the temporary Dutch COVID-19 Act (Tijdelijke wet COVID-19 Justitie en Veiligheid) will be extended, the annual general meeting 2022 of European Healthcare Acquisition & Growth Company B.V. will be held on 23 June 2022 at 10:00 CEST, by means of a virtual meeting, as included in the notice of the annual general meeting of European Healthcare Acquisition & Growth Company B.V. dated 11 May 2022 (www.ehc-company.com), and the present notice will be retracted. The board of the Company will publish a press release as soon as possible after the Dutch government announces whether or not the COVID-19 Act will continue in force in such a manner that the annual general meeting 2022 of European Healthcare Acquisition & Growth Company B.V. can take place at the originally scheduled date of 23 June 2022.

The items on the agenda remain the same and include, amongst others, the adoption of the financial statements for the financial year 2021 and the discharge from liability of the directors.

The reconvening notice and the agenda and explanatory notes thereof, and the proxy form are now available on the website of EHC in the ‘Investor Relations’ section under ‘Shareholders Meeting’: www.ehc-company.com.

The annual report for the financial year 2021, including the financial statements, is available on the website of EHC in the ‘Investor Relations’ section under ‘News & Publications’: www.ehc-company.com, where a downloadable version in the European Single Electronic Format (ESEF) is also available.

European Healthcare Acquisition & Growth Company B.V.

General Enquiries
+49 89 896797200
info@ehc-company.com

Media Enquiries
Finsbury Glover Hering
Kai Peter Rath
+49 211 43079-209
kai.rath@fgh.com

Disclaimer
This press release may include forward-looking statements, which are based on EHC’s current expectations and projections about future events and speak only as of the date hereof. By their nature, forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors because they relate to events and depend on circumstances that will occur in the future whether or not within or outside the control of EHC. Such factors may cause actual results, performance or developments to differ materially from those expressed or implied by such forward-looking statements. accordingly, no undue reliance should be placed on any forward-looking statements. EHC operates in a rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible to predict all risks and uncertainties, nor to assess the impact that these factors will have on EHC. Forward-looking statements speak only as at the date at which they are made and EHC undertakes no obligation to update these forward-looking statements.

This press release contains information that may qualify as inside information within the meaning of Article 7, paragraph 1, of the EU Market Abuse Regulation.